109 results
Page 3 of 6
424B5
jnf0ayg7y7jet8opf
25 Oct 21
Prospectus supplement for primary offering
8:01am
8-K
EX-3.2
hqmrs7 vg9re
30 Sep 21
Amendments to Articles of Incorporation or Bylaws
8:00am
8-K
EX-99.1
i1pf37b9rv cwmt
13 May 21
Selecta Biosciences Reports First Quarter 2021 Financial Results and Provides Business Update
8:01am
8-K
EX-99.1
dxd9rwua3uk8
29 Apr 21
Selecta Biosciences and AskBio Announce Updates to Methylmalonic Acidemia (MMA-101) Program
9:04am
8-K
EX-99.1
qg9s 8m7vc
11 Mar 21
Selecta Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2020 Financial Results
8:01am
8-K
EX-99.1
mnh7ptbnamcue6mlt0mm
6 Jan 21
Selecta Biosciences Announces Data in Non-Human Primates, Further Validating Multiple Potential Benefits of the ImmTORTM Platform in Gene Therapy
8:15am
8-K
EX-99.1
2j9u76pj7c a9fsoc8
5 Nov 20
Selecta Biosciences Reports Third Quarter 2020 Financial Results and Provides Corporate Updates
8:02am
8-K
rtbudvmkp
30 Sep 20
Results of Operations and Financial Condition
4:32pm
8-K
EX-99.1
ana6xndm6 coe
30 Sep 20
Results of Operations and Financial Condition
4:32pm
8-K
EX-1.1
vsiaa06
6 Aug 20
Entry into a Material Definitive Agreement
5:16pm
8-K
EX-99.1
wb9ca qg7
6 Aug 20
Selecta Biosciences Reports Second Quarter 2020 Financial Results and Provides Corporate Updates
8:00am
8-K
EX-99.1
r5hjl
18 Jun 20
Corporate Presentation J u n e 2 0 2 0 SELB
8:50am